Abstract
‘Twitcher’ is a recently recognized mouse mutant which, on the basis of morphological1 and enzymatic2 criteria, represents a murine model for globoid-cell leukodystrophy in man3. In the twitcher mouse, myelin sheaths develop normally in peripheral nerves until about the fifteenth day when the rate of myelination declines, demyelination begins and Krabbe-type inclusions are seen in macrophages and Schwann cells4. With age, demyelination becomes extensive, affecting fibres of all sizes. The axons are relatively spared, although they are smaller than normal. Twitcher peripheral nerves transplanted into normal hosts show, after 2 months, all the characteristics associated with globoid-cell leukodystrophy5. After longer periods of time, however, pathological changes within the grafts appear considerably improved with only occasional evidence of myelin loss, little endoneurial oedema and few globoid cells5. Migration of host Schwann cells into the graft can be excluded as a possible explanation6. In the experiments reported here, we have attempted to determine whether the morphological improvement of grafted twitcher nerves is accompanied by an increase in activity of the enzyme galactosylceramidase. Our results show that galactosylceramidase activity in twitcher sciatic nerves grafted into normal hosts is variable after 1–2 months but indistinguishable from those in the host nerves and much higher than those in intact twitcher nerves after 4.5–9 months. In addition to migration of host Schwann cells, other tissues originating from the host can be excluded as cause of the high enzyme activity. This is the first evidence of long-term in vivo enzyme replacement, accompanied by improved pathology, in a genetic sphingolipidosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Duchen, L. W., Eicher, E. M., Jacobs, J. M., Scaravilli, F. & Teixeira, F. Brain 103, 695–710 (1980).
Kobayashi, T., Yamanaka, T., Jacobs, J. M., Teixeira, F. & Suzuki, K. Brain Res. 202, 479–483 (1980).
Suzuki, K. & Suzuki, Y. in The Metabolic Basis of Inherited Disease 4th edn (eds Stanbury, J. B., Wyngaarden, J. B. & Fredrickson, D. S.) 747 (McGraw-Hill, New York, 1978).
Jacobs, J. M., Scaravilli, F. & De Aranda, F. T. J. neurol. Sci. 55, 285–304 (1982).
Scaravilli, F. & Jacobs, J. M. Nature 290, 56–58 (1981).
Scaravilli, F. & Jacobs, J. M. Brain Res. 237, 163–172 (1982).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. J. biol. Chem. 193, 265–283 (1951).
Susuki, K. Meth. Enzym. 50C, 456–488 (1978).
Suzuki, Y. & Suzuki, K. Science 171, 73–75 (1971).
Suzuki, K., Suzuki, Y. & Fletcher, T. F. in Sphingolipids, Sphingolipidoses and Allied Disorders (eds Volk, B. W. & Aronson, S. M.) 487 (Plenum, New York, 1972).
Brady, R. O., Pentchev, P. G. & Gal, A. E. Fedn Proc. 34, 1310–1315 (1975).
Desnick, R. J., Thorpe, S. R. & Fiddler, M. B. Physiol. Rev. 56, 57–99 (1976).
Desnick, R. J. (ed.) Enzyme Therapy in Genetic Diseases (Liss, New York, 1980).
Hirschhorn, R., Papageorgiou, P. S., Kesarwala, H. H. & Taft, L. T. New Engl. J. Med. 303, 377–380 (1980).
Hobb, J. R. et al., Lancet ii, 709–712 (1981).
Slavin, S. & Yatziv, S. Science 210, 1150–1151 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scaravilli, F., Suzuki, K. Enzyme replacement in grafted nerve of twitcher mouse. Nature 305, 713–715 (1983). https://doi.org/10.1038/305713a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/305713a0
This article is cited by
-
The Myelin Mutants as Models to Study Myelin Repair in the Leukodystrophies
Neurotherapeutics (2011)
-
Mouse Forward Genetics in the Study of the Peripheral Nervous System and Human Peripheral Neuropathy
Neurochemical Research (2009)
-
Enzyme-replacement therapy: Problems and prospects
Pharmaceutisch Weekblad Scientific Edition (1989)
-
Establishment of a galactocerebrosidase-deficient twitcher mouse cell line that expresses galactocerebrosidase activity in hybrids with control human fibroblasts
In Vitro Cellular & Developmental Biology (1988)
-
Disorders in myelination in thetwitcher mutant: Immunohistochemical and biochemical studies
Neurochemical Research (1985)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.